The Level of Patient Participation in Lung and Esophageal Cancer Patients Treated With Definitive Radiochemotherapy.

A Prospective Observational Study on the Level of Patient Participation in Lung and Esophageal Cancer Patients Treated With Definitive Radiochemotherapy.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06019455

Enrollment

500

Registered

2023-08-31

Start date

2022-06-01

Completion date

2027-05-30

Last updated

2024-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Cancer, Lung Cancer

Brief summary

This study aims to assess the level of participation of thoracic cancer patients undergoing definitive radiotherapy and chemotherapy ± immunotherapy in their medical processes and the association between the level of participation and patients' side effects, quality of life, and long-term survival. Additionally, this study will rate the level of participation from both the patients' and medical staff's perspectives and will compare the differences in ratings from these two viewpoints, as well as their impact on treatment outcomes.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Inclusion criteria

* Locally advanced non-small cell lung cancer, limited-stage small cell lung cancer, and esophageal cancer. * Planned to undergo definitive chemoradiotherapy ± immunotherapy; * Males or females aged 18 to 75; * Able to communicate with medical staff.

Exclusion criteria

Patients with cognitive impairments.

Design outcomes

Primary

Measure	Time frame	Description
Incidence of >=Grade 3 toxicities	2 years	The percentage of patients who develop \>=Grade 3 toxicities

Secondary

Measure	Time frame	Description
Overall survival	2 years	2-year survival rate
Progression-free survival	2 years	2-year progression-free survival rate

Countries

China

Contacts

Primary ContactBo Qiu

qiubo@sysucc.org.cn+862087343031

Outcome results